Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation

Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation

Abstract Background Forty percent of babies who are stillborn born die after 36 weeks gestation and have no lethal structural abnormality. Maternal perception of reduced fetal movement (RFM) is associated with stillbirth and is related to abnormal placental structure and function. The ultimate objec...

Full description

Bibliographic Details
Main Authors: Lindsay Armstrong-Buisseret, Eleanor Mitchell, Trish Hepburn, Lelia Duley, Jim G. Thornton, Tracy E. Roberts, Claire Storey, Rebecca Smyth, Alexander E. P. Heazell
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Trials
Subjects:
Reduced fetal movement
Placental biomarker
sFlt-1/PlGF ratio
Placenta
Maternal serum
Stillbirth
Online Access:http://link.springer.com/article/10.1186/s13063-018-2859-1

Internet

http://link.springer.com/article/10.1186/s13063-018-2859-1

Similar Items